BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 24311990)

  • 1. Timing and completeness of trial results posted at ClinicalTrials.gov and published in journals.
    Riveros C; Dechartres A; Perrodeau E; Haneef R; Boutron I; Ravaud P
    PLoS Med; 2013 Dec; 10(12):e1001566; discussion e1001566. PubMed ID: 24311990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of serious adverse events posted at ClinicalTrials.gov and published in corresponding journal articles.
    Tang E; Ravaud P; Riveros C; Perrodeau E; Dechartres A
    BMC Med; 2015 Aug; 13():189. PubMed ID: 26269118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Public availability of results of observational studies evaluating an intervention registered at ClinicalTrials.gov.
    Baudart M; Ravaud P; Baron G; Dechartres A; Haneef R; Boutron I
    BMC Med; 2016 Jan; 14():7. PubMed ID: 26819213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reporting of statistically significant results at ClinicalTrials.gov for completed superiority randomized controlled trials.
    Dechartres A; Bond EG; Scheer J; Riveros C; Atal I; Ravaud P
    BMC Med; 2016 Nov; 14(1):192. PubMed ID: 27899150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trial publication after registration in ClinicalTrials.Gov: a cross-sectional analysis.
    Ross JS; Mulvey GK; Hines EM; Nissen SE; Krumholz HM
    PLoS Med; 2009 Sep; 6(9):e1000144. PubMed ID: 19901971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fate of prospective spine studies registered on www.ClinicalTrials.gov.
    Ohnmeiss DD
    Spine J; 2015 Mar; 15(3):487-91. PubMed ID: 25315132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reporting of clinical trial safety results in ClinicalTrials.gov for FDA-approved drugs: A cross-sectional analysis.
    Chen KY; Borglund EM; Postema EC; Dunn AG; Bourgeois FT
    Clin Trials; 2022 Aug; 19(4):442-451. PubMed ID: 35482320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ClinicalTrials.gov and Drugs@FDA: A Comparison of Results Reporting for New Drug Approval Trials.
    Schwartz LM; Woloshin S; Zheng E; Tse T; Zarin DA
    Ann Intern Med; 2016 Sep; 165(6):421-30. PubMed ID: 27294570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trial registration, publication rate and characteristics in the research field of otology: A cross-sectional study.
    van Heteren JAA; van Beurden I; Peters JPM; Smit AL; Stegeman I
    PLoS One; 2019; 14(7):e0219458. PubMed ID: 31291350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of reporting phase III randomized controlled trials of antibiotic treatment for common bacterial infections in ClinicalTrials.gov and matched publications.
    Shepshelovich D; Yelin D; Gafter-Gvili A; Goldman S; Avni T; Yahav D
    Clin Microbiol Infect; 2018 Nov; 24(11):1211.e9-1211.e14. PubMed ID: 29454846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do Published Data in Trials Assessing Cancer Drugs Reflect the Real Picture of Efficacy and Safety?
    Lv JW; Chen YP; Zhou GQ; Liu X; Guo Y; Mao YP; Ma J; Sun Y
    J Natl Compr Canc Netw; 2017 Nov; 15(11):1363-1371. PubMed ID: 29118228
    [No Abstract]   [Full Text] [Related]  

  • 12. Non-publication and delayed publication of randomized trials on vaccines: survey.
    Manzoli L; Flacco ME; D'Addario M; Capasso L; De Vito C; Marzuillo C; Villari P; Ioannidis JP
    BMJ; 2014 May; 348():g3058. PubMed ID: 24838102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Public availability of results of trials assessing cancer drugs in the United States.
    Nguyen TA; Dechartres A; Belgherbi S; Ravaud P
    J Clin Oncol; 2013 Aug; 31(24):2998-3003. PubMed ID: 23878298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reporting discrepancies between the ClinicalTrials.gov results database and peer-reviewed publications.
    Hartung DM; Zarin DA; Guise JM; McDonagh M; Paynter R; Helfand M
    Ann Intern Med; 2014 Apr; 160(7):477-83. PubMed ID: 24687070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of reporting phase I trial results in ClinicalTrials.gov and matched publications.
    Shepshelovich D; Goldvaser H; Wang L; Abdul Razak AR; Bedard PL
    Invest New Drugs; 2017 Dec; 35(6):827-833. PubMed ID: 28905282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trial reporting performance of thirty UK universities on ClinicalTrials.gov-evaluation of a new tracking tool for the US clinical trial registry.
    Keestra SM; Rodgers F; Lenz D; Osborne R; Bruckner T; Lee S
    Trials; 2021 Jun; 22(1):375. PubMed ID: 34074329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of trial registration with the results and conclusions of published trials of new oncology drugs.
    Rasmussen N; Lee K; Bero L
    Trials; 2009 Dec; 10():116. PubMed ID: 20015404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unpublished completed obstetric randomized clinical trials registered at ClinicalTrials.gov: how big is this issue?
    Gupta M; Oliver EA; Chauhan SP; Wagner SM; Mol B; Berghella V
    Am J Obstet Gynecol MFM; 2023 Sep; 5(9):101066. PubMed ID: 37419451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Oncology Trial Results Reporting Over a 10-Year Period.
    Liu X; Zhang Y; Li WF; Vokes E; Sun Y; Le QT; Ma J
    JAMA Netw Open; 2021 May; 4(5):e2110438. PubMed ID: 34028549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis.
    Ross JS; Tse T; Zarin DA; Xu H; Zhou L; Krumholz HM
    BMJ; 2012 Jan; 344():d7292. PubMed ID: 22214755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.